Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperprolactinemia]

M Oesterle1, R L Galeazzi

  • 1Medizinische Klinik A, Endokrinologie, Kantonsspital St. Gallen.

Praxis
|June 20, 1995
PubMed
Summary

Elevated serum prolactin levels can be physiological or pathological. Differentiating causes like medications, hypothyroidism, and pituitary tumors is crucial for effective treatment and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From signal generation to proof of new drug event combinations in the comprehensive hospital drug monitoring, Berne/St. Gallen, 1974-1993; four examples.

Pharmacoepidemiology and drug safety·2004
Same author

Follow-up examination at the age of 15 months of extremely preterm infants after postnatal estradiol and progesterone replacement.

The Journal of clinical endocrinology and metabolism·2001
Same author

Cutaneous pseudolymphoma associated with bromocriptine therapy.

Clinical endocrinology·2000
Same author

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine.

British journal of clinical pharmacology·2000
Same author

[Unexpected development during rehabilitation for suspected rheumatic disorder].

Praxis·1999
Same author

Medullary thyroid carcinoma in Graves' disease.

Clinical endocrinology·1999

Area of Science:

  • Clinical endocrinology
  • Reproductive medicine
  • Oncology

Context:

  • Elevated serum prolactin (hyperprolactinemia) is a common clinical finding.
  • Causes include physiological states (pregnancy, lactation), medications (dopamine antagonists, estrogens), and primary hypothyroidism.
  • Distinguishing hyperprolactinemia from pituitary tumors (prolactinomas) is essential.

Purpose:

  • To review the differential diagnosis of hyperprolactinemia.
  • To discuss treatment strategies for prolactinomas, including medical and surgical options.
  • To outline management considerations during pregnancy.

Summary:

  • Hyperprolactinemia can stem from various causes, necessitating careful diagnosis.
  • Dopamine agonist therapy often reduces prolactin levels but rarely cures prolactinomas.
  • Surgical success rates for prolactinomas vary by tumor size, with microadenomas having better outcomes than macroadenomas.

Impact:

  • Informs clinical decision-making regarding the management of hyperprolactinemia and prolactinomas.
  • Highlights the importance of multidisciplinary collaboration between surgeons and endocrinologists.
  • Provides guidance on managing prolactinomas in pregnant patients, emphasizing clinical monitoring and timely intervention.

Related Experiment Videos